Jason Kovac
Urology · Carmel, INNPI 1033462239
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $93,441 of the $111,950 with a category attached, or 83.5%. 30 manufacturers reported payments, led by Antares Pharma, Inc. at 57.5% of the total. Reporting peaked in 2022 at $46,303 and has fallen 99.8% since, to $111 in 2025. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 373 payments — averaging $300.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Antares Pharma, Inc.$64K
- Clarus Therapeutics Inc.$31K
- Acerus Pharmaceuticals Corporation$9K
- Boston Scientific$3K
- Aytu Biopharma, Inc.$2K
- Coloplast$643
- plus $2K from 24 others
Across 56 payments — averaging $2460.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$135K
- Acerus Pharmaceuticals Corporation$3K
What the payments were for
- Speaking & faculty fees$93,44183%
- Travel & lodging$11,20510%
- Food & beverage$7,3037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Antares Pharma, Inc. | 116 | $64,317 |
| Clarus Therapeutics Inc. | 66 | $31,159 |
| Acerus Pharmaceuticals Corporation | 17 | $9,194 |
| Boston Scientific | 32 | $2,636 |
| Aytu Biopharma, Inc. | 5 | $1,794 |
| Coloplast | 12 | $643 |
| Endo Pharmaceuticals Inc. | 19 | $434 |
| Endo USA, Inc. | 12 | $234 |
| Sanofi | 12 | $226 |
| Halozyme Inc | 7 | $209 |
| Astellas Pharma US Inc | 10 | $155 |
| Johnson & Johnson | 9 | $146 |
| Myovant Sciences Inc. | 8 | $134 |
| Zyla Life Sciences, Inc. | 12 | $116 |
| Myriad Genetic Laboratories, Inc. | 5 | $84 |
| Tolmar, Inc. | 4 | $78 |
| Tolmar Pharmaceuticals, Inc. | 3 | $62 |
| Pfizer | 5 | $58 |
| Sun Pharmaceutical Industries Inc. | 4 | $57 |
| Merck | 3 | $51 |
| Amgen | 3 | $37 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Bayer | 1 | $17 |
| Foundation Medicine, Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
| Clinigen, Inc. | 1 | $13 |
| Blue Earth Diagnostics | 1 | $12 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $12 |
| Janssen Scientific Affairs, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$111,950 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.
Other urology in Carmel
- Alexander TatemCarmel$418K
- Chad ReichardCarmel$400K
- Matthew MellonCarmel$159K
- Kenneth NeyCarmel$55K
- Jeremiah DallmerCarmel$52K
- Scott FarnhamCarmel$30K
- Megan BockCarmel$28K
- Joshua RingCarmel$13K
- Clinton BahlerCarmel$11K
- Scott PikeCarmel$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.